1. Short title This Act may be cited as the Medical Information Nuanced Accountability Judgement Act of 2023 or the MINAJ Act of 2023 . 2. Prohibition against vaccine mandates prior to marketing approval for at least 10 years (a) Prohibition The Federal Government shall not establish, implement, or enforce any mandate requiring an individual to receive a vaccine that has not been authorized for marketing for at least 10 years. (b) Public health emergency exception Subsection (a) does not apply if— (1) the mandate is intended to prevent or mitigate a disease with respect to which a public health emergency declaration is in effect; and (2) the Federal department or agency seeking to impose the mandate— (A) submits a report to the appropriate committees of Congress— (i) giving notice of the intent to impose the mandate; and (ii) including all data in the possession of the department or agency on the safety and efficacy of the vaccine involved; and (B) gives the appropriate committees of Congress a sufficient period to conduct extensive review of the matters in such report. (c) Sufficient period of time For purposes of subsection (b)(2)(B), a sufficient period shall be the lesser of— (1) 3 months; and (2) the period over which the appropriate committees of Congress each complete three hearings on the matters in the report submitted under subsection (b)(2)(A). (d) Definitions In this section: (1) The term appropriate committees of Congress means— (A) the Committee on Energy and Commerce of the House of Representatives; and (B) the Committee on Health, Education, Labor, and Pensions of the Senate. (2) The term authorized for marketing means licensed, approved, or authorized under— (A) section 351 of the Public Health Service Act ( 42 U.S.C. 262 ); or (B) section 505 or 564 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 355 , 360bbb–3). (3) The term mandate includes any condition imposed on— (A) hiring or employment